Telcon RF Pharmaceutical has ranked among the top searched stocks for 17 days in the past month.


As of 10:31 AM on the 22nd, Telcon RF Pharmaceutical is trading at 6,850 KRW, up 2.39% from the previous day. This is a 31.43% decrease compared to September 24. Telcon RF Pharmaceutical is known as a manufacturer of components for wireless communication equipment.

Today, foreigners have a net purchase of 87,000 shares of Telcon RF Pharmaceutical, while institutions have a net sale of 1,000 shares, according to provisional data. Over the past five days, individual investors have net sold 5,738 shares, while foreigners and institutions have net bought 157,945 shares and net sold 109,919 shares, respectively.


On October 15, Telcon RF Pharmaceutical was an issue in the market with the headline "Rise on news of Humanigen therapeutic clinical trials."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing